Henan Lingrui Pharmaceutical Co Ltd (600285) — Long-term Investment Intensity
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Long-term Investment Intensity of 11.1% as of September 2019. Long-term investments of CN¥382.73 Million represent 11.1% of total assets of CN¥3.45 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Henan Lingrui Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Henan Lingrui Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 11.1%, reflecting long-term investments of CN¥382.73 Million against total assets of CN¥3.45 Billion CNY. Also explore 600285 total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Henan Lingrui Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Henan Lingrui Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600285 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 8.9% | CN¥278.14 Million | CN¥3.11 Billion | ▼ -3.6 pp |
| 2017 | 12.5% | CN¥413.34 Million | CN¥3.31 Billion | ▲ +0.2 pp |
| 2016 | 12.3% | CN¥367.25 Million | CN¥2.98 Billion | ▼ -17.6 pp |
| 2015 | 29.9% | CN¥811.08 Million | CN¥2.71 Billion | — |